RainDance Inks Deals with 454, Ambry Targeting ADME Applications
March 07, 2011
RainDance Inks Deals with 454, Ambry Targeting ADME Applications
RainDance is partnering with Roche 454 and Ambry in two separate alliances aimed at developing ADME gene screening panels for use on next-generation sequencing instruments.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.